Critical evaluation of the human relevance of the mode of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR)

References

• Allen DG, Pearse G, Haseman JK, Maronpot RR. 2004. Prediction of rodent carcinogenesis: an evaluation of prechronic liver lesions as forecasters of liver tumors in NTP carcinogenicity studies. Toxicol Pathol. 32(4):393–401.
   PubMed Web of Science ®Google Scholar
• Allen JW, Wolf DC, George MH, Hester SD, Sun G, Thai SF, Delker DA, Moore T, Jones C, Nelson G, et al. 2006. Toxicity profiles in mice treated with hepatotumorigenic and non-hepatotumorigenic triazole conazole fungicides: propiconazole, triadimefon, and myclobutanil. Toxicol Pathol. 34(7):853–862.
   PubMed Web of Science ®Google Scholar
• Andersen ME, Preston RJ, Maier A, Willis AM, Patterson J. 2014. Dose–response approaches for nuclear receptor-mediated modes of action for liver carcinogenicity: results of a workshop. Crit Rev Toxicol. 44(1):50–63.
   PubMed Web of Science ®Google Scholar
• Boffetta P, Desai V. 2018. Exposure to permethrin and cancer risk: a systematic review. Crit Rev Toxicol. 48(6):433–442.
   PubMed Web of Science ®Google Scholar
• Bogen KT. 2018. Biphasic hCAR inhibition-activation by two aminoazo liver carcinogens. Nucl Recept Res. 5:12.
   Google Scholar
• Bonovas S, Nikolopoulos GK, Bagos PG. 2012. Use of fibrates and cancer risk: a systematic review and meta-analysis of 17 long-term randomized placebo-controlled trials. PLoS One. 7(9):e45259.
   PubMed Web of Science ®Google Scholar
• Boobis AR, Cohen SM, Dellarco V, McGregor D, Meek ME, Vickers C, Willcocks D, Farland W. 2006. IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit Rev Toxicol. 36(10):781–792.
   PubMed Web of Science ®Google Scholar
• Boobis AR, Doe JE, Heinrich-Hirsch B, Meek ME, Munn S, Ruchirawat M, Schlatter J, Seed J, Vickers C. 2008. IPCS framework for analyzing the relevance of a noncancer mode of action for humans. Crit Rev Toxicol. 38(2):87–96.
   PubMed Web of Science ®Google Scholar
• Braeuning A. 2014. Liver cell proliferation and tumor promotion by phenobarbital: relevance for humans? Arch Toxicol. 88(10):1771–1772.
   PubMed Web of Science ®Google Scholar
• Braeuning A, Gavrilov A, Brown S, Wolf CR, Henderson CJ, Schwarz M. 2014. Phenobarbital-mediated tumor promotion in transgenic mice with humanized CAR and PXR. Toxicol Sci. 140(2):259–270.
   PubMed Web of Science ®Google Scholar
• Braeuning A, Pavek P. 2020. β-Catenin signaling, the constitutive androstane receptor and their mutual interactions. Arch Toxicol. 94(12):3983–3991.
   PubMed Web of Science ®Google Scholar
• Braeuning A, Schwarz M. 2016. Is the question of phenobarbital as potential liver cancer risk factor for humans really resolved? Arch Toxicol. 90(6):1525–1526.
   PubMed Web of Science ®Google Scholar
• Bucher JR, Shackelford CC, Haseman JK, Johnson JD, Kurtz PJ, Persing RL. 1994. Carcinogenicity studies of oxazepam in mice. Fundam Appl Toxicol. 23(2):280–297.
   PubMedGoogle Scholar
• Butler WH, Gabriel KL, Osimitz TG, Preiss FJ. 1998. Oncogenicity studies of piperonyl butoxide in rats and mice. Hum Exp Toxicol. 17(6):323–330.
   PubMed Web of Science ®Google Scholar
• Cabral JRP, Hall RK, Bronczyk SA, Shubik P. 1979. A carcinogenicity study of the pesticide dieldrin in hamsters. Cancer Lett. 6(4–5):241–246.
   PubMed Web of Science ®Google Scholar
• Cabral JR, Hall RK, Rossi L, Bronczyk SA, Shubik P. 1982. Lack of carcinogenicity of DDT in hamsters. Tumori. 68(1):5–10.
   PubMed Web of Science ®Google Scholar
• Carthew P, Edwards RE, Nolan BM. 1998. The quantitative distinction of hyperplasia from hypertrophy in hepatomegaly induced in the rat liver by phenobarbital. Toxicol Sci. 44(1):46–51.
   PubMed Web of Science ®Google Scholar
• Choi HS, Chung M, Tzameli I, Simha D, Lee YK, Seol W, Moore DD. 1997. Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR. J Biol Chem. 272(38):23565–23571.
   PubMed Web of Science ®Google Scholar
• Choi CJ, Rushton EK, Vardy A, Higgins L, Augello A, Parod RJ. 2017. Mode of action and human relevance of THF-induced mouse liver tumors. Toxicol Lett. 276:138–143.
   PubMed Web of Science ®Google Scholar
• Cohen SM. 2004. Human carcinogenic risk evaluation: an alternative approach to the two-year rodent bioassay. Toxicol Sci. 80(2):225–229.
   PubMed Web of Science ®Google Scholar
• Cohen SM. 2010. Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary. Toxicol Pathol. 38(3):487–501.
   PubMed Web of Science ®Google Scholar
• Cohen SM. 2017. The relevance of experimental carcinogenicity studies to human safety. Curr Opin Toxicol. 3:6–11.
   Google Scholar
• Cohen SM, Arnold LL. 2011. Chemical carcinogenesis. Toxicol Sci. 120(Suppl. 1):S76–S92.
   PubMedGoogle Scholar
• Cohen SM, Arnold LL. 2016. Critical role of toxicologic pathology in a short-term screen for carcinogenicity. J Toxicol Pathol. 29(4):215–227.
   PubMed Web of Science ®Google Scholar
• Cohen SM, Boobis AR, Dellarco VL, Doe JE, Fenner-Crisp PA, Moretto A, Pastoor TP, Schoeny RS, Seed JG, Wolf DC. 2019. Chemical carcinogenicity revisited 3: risk assessment of carcinogenic potential based on the current state of knowledge of carcinogenesis in humans. Regul Toxicol Pharmacol. 103:100–105.
   PubMed Web of Science ®Google Scholar
• Cohen SM, Ellwein LB. 1990. Cell proliferation in carcinogenesis. Science. 249(4972):1007–1011.
   PubMed Web of Science ®Google Scholar
• Cohen SM, Klaunig J, Meek ME, Hill RN, Pastoor T, Lehman-McKeeman L, Bucher J, Longfellow DG, Seed J, Dellarco V, et al. 2004. Evaluating the human relevance of chemically induced animal tumors. Toxicol Sci. 78(2):181–186.
   PubMed Web of Science ®Google Scholar
• Corton JC, Cunningham ML, Hummer BT, Lau C, Meek B, Peters JM, Popp JA, Rhomberg L, Seed J, Klaunig JE. 2014. Mode of action framework analysis for receptor-mediated toxicity: the peroxisome proliferator-activated receptor alpha (PPARα) as a case study. Crit Rev Toxicol. 44(1):1–49.
   PubMed Web of Science ®Google Scholar
• Corton JC, Peters JM, Klaunig JE. 2018. The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions. Arch Toxicol. 92(1):83–119.
   PubMed Web of Science ®Google Scholar
• Craig E, Lowe K, Akerman G, Dawson J, May B, Reaves E, Lowit A. 2019. Reducing the need for animal testing while increasing efficiency in a pesticide regulatory setting: lessons from the EPA Office of Pesticide Programs' Hazard and Science Policy Council. Regul Toxicol Pharmacol. 108:104481.
   PubMed Web of Science ®Google Scholar
• Cui X, Thomas A, Han Y, Palamanda J, Montgomery D, White RE, Morrison RA, Cheng KC. 2005. Quantitative PCR assay for cytochromes P450 2B and 3A induction in rat precision-cut liver slices: correlation study with induction in vivo. J Pharmacol Toxicol Methods. 52(2):234–243.
   PubMedGoogle Scholar
• Cunningham ML, Maronpot RR, Thompson M, Bucher JR. 1994. Early responses of the liver of B6C3F1 mice to the hepatocarcinogen oxazepam. Toxicol Appl Pharmacol. 124(1):31–38.
   PubMed Web of Science ®Google Scholar
• Currie RA, Peffer RC, Goetz AK, Omiecinski CJ, Goodman JI. 2014. Phenobarbital and propiconazole toxicogenomic profiles in mice show major similarities consistent with the key role that constitutive androstane receptor (CAR) activation plays in their mode of action. Toxicology. 321:80–88.
   PubMed Web of Science ®Google Scholar
• Daujat-Chavanieu M, Gerbal-Chaloin S. 2020. Regulation of CAR and PXR expression in health and disease. Cells. 9(11):2395.
   Web of Science ®Google Scholar
• de la Iglesia FA, Barsoum N, Gough A, Mitchell L, Martin RA, Di Fonzo C, McGuire EJ. 1981. Carcinogenesis bioassay of prazepam (Verstran) in rats and mice. Toxicol Appl Pharmacol. 57(1):39–54.
   PubMed Web of Science ®Google Scholar
• de la Rosa Rodriguez MA, Sugahara G, Hooiveld G, Ishida Y, Tateno C, Kersten S. 2018. The whole transcriptome effects of the PPARalpha agonist fenofibrate on livers of hepatocyte humanized mice. BMC Genomics. 19(1):443.
   PubMedGoogle Scholar
• Deguchi Y, Yamada T, Hirose Y, Nagahori H, Kushida M, Sumida K, Sukata T, Tomigahara Y, Nishioka K, Uwagawa S, et al. 2009. Mode of action analysis for the synthetic pyrethroid metofluthrin-induced rat liver tumors: evidence for hepatic CYP2B induction and hepatocyte proliferation. Toxicol Sci. 108(1):69–80.
   PubMed Web of Science ®Google Scholar
• Dekant W. 2019. Tetrahydrofuran-induced tumors in rodents are not relevant to humans: quantitative weight of evidence analysis of mode of action information does not support classification of tetrahydrofuran as a possible human carcinogen. Regul Toxicol Pharmacol. 109:104499.
   PubMed Web of Science ®Google Scholar
• Devereux TR, Anna CH, Foley JF, White CM, Sills RC, Barrett JC. 1999. Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis. Oncogene. 18(33):4726–4733.
   PubMed Web of Science ®Google Scholar
• Diwan BA, Ward JM, Anderson LM, Hagiwara A, Rice JM. 1986. Lack of effect of phenobarbital on hepatocellular carcinogenesis initiated by N-nitrosodiethylamine or methylazoxymethanol acetate in male Syrian golden hamsters. Toxicol Appl Pharmacol. 86(2):298–307.
   PubMed Web of Science ®Google Scholar
• Doe JE, Boobis AR, Dellarco V, Fenner-Crisp PA, Moretto A, Pastoor TP, Schoeny RS, Seed JG, Wolf DC. 2019. Chemical carcinogenicity revisited 2: current knowledge of carcinogenesis shows that categorization as a carcinogen or non-carcinogen is not scientifically credible. Regul Toxicol Pharmacol. 103:124–129.
   PubMed Web of Science ®Google Scholar
• Dong B, Lee JS, Park YY, Yang F, Xu G, Huang W, Finegold MJ, Moore DD. 2015. Activating CAR and β-catenin induces uncontrolled liver growth and tumorigenesis. Nat Commun. 6:5944.
   PubMed Web of Science ®Google Scholar
• Elcombe CR, Peffer RC, Wolf DC, Bailey J, Bars R, Bell D, Cattley RC, Ferguson SS, Geter D, Goetz A, et al. 2014. Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: a case study with phenobarbital as a model constitutive androstane receptor (CAR) activator. Crit Rev Toxicol. 44(1):64–82.
   PubMed Web of Science ®Google Scholar
• Ellwein LB, Cohen SM. 1988. A cellular dynamics model of experimental bladder cancer: analysis of the effect of sodium saccharin in the rat. Risk Anal. 8(2):215–221.
   PubMed Web of Science ®Google Scholar
• Faucette SR, Zhang TC, Moore R, Sueyoshi T, Omiecinski CJ, LeCluyse EL, Negishi M, Wang H. 2007. Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers. J Pharmacol Exp Ther. 320(1):72–80.
   PubMed Web of Science ®Google Scholar
• Foster JR, Lund G, Sapelnikova S, Tyrrell DL, Kneteman NM. 2014. Chimeric rodents with humanized liver: bridging the preclinical/clinical trial gap in ADME/toxicity studies. Xenobiotica. 44(2):109–122.
   PubMed Web of Science ®Google Scholar
• Franzosa JA, Bonzo JA, Jack J, Baker NC, Kothiya P, Witek RP, Hurban P, Siferd S, Hester S, Shah I, et al. 2021. High-throughput toxicogenomic screening of chemicals in the environment using metabolically competent hepatic cell cultures. NPJ Syst Biol Appl. 7(1):7.
   PubMed Web of Science ®Google Scholar
• Friedman GD, Jiang S-F, Udaltsova N, Quesenberry CP, Chan J, Habel LA. 2009. Epidemiologic evaluation of pharmaceuticals with limited evidence of carcinogenicity. Int J Cancer. 125(9):2173–2178.
   PubMed Web of Science ®Google Scholar
• Gamer AO, Jaeckh R, Leibold E, Kaufmann W, Gembardt C, Bahnemann R, van Ravenzwaay B. 2002. Investigations on cell proliferation and enzyme induction in male rat kidney and female mouse liver caused by tetrahydrofuran. Toxicol Sci. 70(1):140–149.
   PubMed Web of Science ®Google Scholar
• Goettel M, Fegert I, Honarvar N, Vardy A, Haines C, Chatham LR, Lake BG. 2020. Comparative studies on the effects of sodium phenobarbital and two other constitutive androstane receptor (CAR) activators on induction of cytochrome P450 enzymes and replicative DNA synthesis in cultured hepatocytes from wild type and CAR knockout rats. Toxicology. 433–434:152394.
   PubMed Web of Science ®Google Scholar
• Gold LS, Manley NB, Slone TH, Ward JM. 2001. Compendium of chemical carcinogens by target organ: results of chronic bioassays in rats, mice, hamsters, dogs, and monkeys. Toxicol Pathol. 29(6):639–652.
   PubMed Web of Science ®Google Scholar
• Goodman JI. 2018. Goodbye to the bioassay. Toxicol Res (Camb). 7(4):558–564.
   PubMed Web of Science ®Google Scholar
• Goodman JI, Brusick DJ, Busey WM, Cohen SM, Lamb JC, Starr TB. 2000. Reevaluation of the cancer potency factor of toxaphene: recommendations from a peer review panel. Toxicol Sci. 55(1):3–16.
   PubMed Web of Science ®Google Scholar
• Graillot C, Gak JC, Lancret C, Truhaut R. 1975. Research on the modalities and mechanisms of toxic action of organochlorine insecticides. II. Long term toxicity effects of DDT in hamsters. Eur J Toxicol Environ Hyg. 8(6):353–359.
   PubMedGoogle Scholar
• Greenfield RE, Ellwein LB, Cohen SM. 1984. A general probabilistic model of carcinogenesis: analysis of experimental urinary bladder cancer. Carcinogenesis. 5(4):437–445.
   PubMed Web of Science ®Google Scholar
• Griffin RJ, Burka LT, Cunningham ML. 1995. Activity of hepatic drug metabolizing enzymes following oxazepam-dosed feed treatment in B6C3F1 mice. Toxicol Lett. 76(3):251–256.
   PubMed Web of Science ®Google Scholar
• Griffin RJ, Dudley CN, Cunningham ML. 1996. Biochemical effects of the mouse hepatocarcinogen oxazepam: similarities to phenobarbital. Fundam Appl Toxicol. 29(1):147–154.
   PubMedGoogle Scholar
• Haines C, Chatham LR, Vardy A, Elcombe CR, Foster JR, Lake BG. 2018a. Comparison of the hepatic and thyroid gland effects of sodium phenobarbital in wild type and constitutive androstane receptor (CAR) knockout rats and pregnenolone-16α-carbonitrile in wild type and pregnane X receptor (PXR) knockout rats. Toxicology. 400–401:20–27.
   PubMed Web of Science ®Google Scholar
• Haines C, Chatham LR, Vardy A, Elcombe CR, Foster JR, Lake BG. 2019. Comparison of the hepatic and thyroid gland effects of sodium phenobarbital and pregnenolone-16α-carbonitrile in wild-type and constitutive androstane receptor (CAR)/pregnane X receptor (PXR) knockout rats. Xenobiotica. 49(2):227–238.
   PubMed Web of Science ®Google Scholar
• Haines C, Elcombe BM, Chatham LR, Vardy A, Higgins LG, Elcombe CR, Lake BG. 2018b. Comparison of the effects of sodium phenobarbital in wild type and humanized constitutive androstane receptor (CAR)/pregnane X receptor (PXR) mice and in cultured mouse, rat and human hepatocytes. Toxicology. 396–397:23–32.
   PubMed Web of Science ®Google Scholar
• Harada T, Takeda M, Kojima S, Tomiyama N. 2016. Toxicity and carcinogenicity of dichlorodiphenyltrichloroethane (DDT). Toxicol Res. 32(1):21–33.
   PubMed Web of Science ®Google Scholar
• Hester S, Moore T, Padgett WT, Murphy L, Wood CE, Nesnow S. 2012. The hepatocarcinogenic conazoles: cyproconazole, epoxiconazole, and propiconazole induce a common set of toxicological and transcriptional responses. Toxicol Sci. 127(1):54–65.
   PubMed Web of Science ®Google Scholar
• Heusinkveld H, Braakhuis H, Gommans R, Botham P, Corvaro M, van der Laan JW, Lewis D, Madia F, Manou I, Schorsch F, et al. 2020. Towards a mechanism-based approach for the prediction of nongenotoxic carcinogenic potential of agrochemicals. Crit Rev Toxicol. 50(9):725–739.
   PubMed Web of Science ®Google Scholar
• Hirose Y, Nagahori H, Yamada T, Deguchi Y, Tomigahara Y, Nishioka K, Uwagawa S, Kawamura S, Isobe N, Lake BG, et al. 2009. Comparison of the effects of the synthetic pyrethroid metofluthrin and phenobarbital on CYP2B form induction and replicative DNA synthesis in cultured rat and human hepatocytes. Toxicology. 258(1):64–69.
   PubMed Web of Science ®Google Scholar
• Hoflack JC, Mueller L, Fowler S, Braendli-Baiocco A, Flint N, Kuhlmann O, Singer T, Roth A. 2012. Monitoring Cyp2b10 mRNA expression at cessation of 2-year carcinogenesis bioassay in mouse liver provides evidence for a carcinogenic mechanism devoid of human relevance: the dalcetrapib experience. Toxicol Appl Pharmacol. 259(3):355–365.
   PubMed Web of Science ®Google Scholar
• Holsapple MP, Pitot HC, Cohen SM, Cohen SH, Boobis AR, Klaunig JE, Pastoor T, Dellarco VL, Dragan YP. 2006. Mode of action in relevance of rodent liver tumors to human cancer risk. Toxicol Sci. 89(1):51–56.
   PubMed Web of Science ®Google Scholar
• Huang W, Zhang J, Washington M, Liu J, Parant JM, Lozano G, Moore DD. 2005. Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. Mol Endocrinol. 19(6):1646–1653.
   PubMedGoogle Scholar
• Huff J, Cirvello J, Haseman J, Bucher J. 1991. Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents. Environ Health Perspect. 93:247–270.
   PubMed Web of Science ®Google Scholar
• Hughes BJ, Thomas J, Lynch AM, Borghoff SJ, Green S, Mensing T, Sarang SS, LeBaron MJ. 2016. Methyl isobutyl ketone-induced hepatocellular carcinogenesis in B6C3F1 mice: a constitutive androstane receptor (CAR)-mediated mode of action. Regul Toxicol Pharmacol. 81:421–429.
   PubMed Web of Science ®Google Scholar
• IARC. 1996. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 66, some pharmaceutical drugs. Lyon, France: IARC Press; p. 37–96.
   Google Scholar
• IARC. 2001. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 79, some thyrotropic agents: phenobarbital and its sodium salt. Lyon, France: IARC Press; p. 161–288.
   Google Scholar
• IARC. 2018. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 113. DDT, lindane, and 2,4-D. Lyon, France: IARC Press; p. 37–266.
   Google Scholar
• IPCS. 1999. CARBAMAZEPINE International Programme on Chemical Safety poisons information monograph 100 Pharmaceutical. Updated by Dr M.O. Rambourg-Schepens & Dr L. Murray; [accessed 2021 May 14]. http://www.inchem.org/documents/pims/pharm/pim100.htm#SectionTitle:7.3%20%20Carcinogenicity.
   Google Scholar
• Iqbal U, Nguyen PA, Syed-Abdul S, Yang HC, Huang CW, Jian WS, Hsu MH, Yen Y, Li YC. 2015. Is long-term use of benzodiazepine a risk for cancer? Medicine (Baltimore). 94(6):e483.
   PubMed Web of Science ®Google Scholar
• James NH, Roberts RA. 1996. Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis. Carcinogenesis. 17(8):1623–1632.
   PubMed Web of Science ®Google Scholar
• Jones HB, Orton TC, Lake BG. 2009. Effect of chronic phenobarbitone administration on liver tumour formation in the C57BL/10J mouse. Food Chem Toxicol. 47(6):1333–1340.
   PubMed Web of Science ®Google Scholar
• Kanno Y, Suzuki M, Miyazaki Y, Matsuzaki M, Nakahama T, Kurose K, Sawada J, Inouye Y. 2007. Difference in nucleocytoplasmic shuttling sequences of rat and human constitutive active/androstane receptor. Biochim Biophys Acta. 1773(6):934–944.
   PubMed Web of Science ®Google Scholar
• Kazantseva YA, Yarushkin AA, Pustylnyak VO. 2013. Dichlorodiphenyltrichloroethane technical mixture regulates cell cycle and apoptosis genes through the activation of CAR and ERα in mouse livers. Toxicol Appl Pharmacol. 271(2):137–143.
   PubMed Web of Science ®Google Scholar
• Khasawinah AM, Grutsch JF. 1989. Chlordane: thirty-month tumorigenicity and chronic toxicity test in rats. Regul Toxicol Pharmacol. 10(2):95–109.
   PubMed Web of Science ®Google Scholar
• Kiyosawa N, Kwekel JC, Burgoon LD, Williams KJ, Tashiro C, Chittim B, Zacharewski TR. 2008. o,p′-DDT elicits PXR/CAR-, not ER-, mediated responses in the immature ovariectomized rat liver. Toxicol Sci. 101(2):350–363.
   PubMed Web of Science ®Google Scholar
• Kolaja KL, Stevenson DE, Johnson JT, Walborg EF Jr, Klaunig JE. 1996. Subchronic effects of dieldrin and phenobarbital on hepatic DNA synthesis in mice and rats. Fundam Appl Toxicol. 29(2):219–228.
   PubMedGoogle Scholar
• Kondo M, Kikumoto H, Osimitz TG, Cohen SM, Lake BG, Yamada T. 2020. An evaluation of the human relevance of the liver tumors observed in female mice treated with permethrin based on mode of action. Toxicol Sci. 175(1):50–63.
   PubMed Web of Science ®Google Scholar
• Kondo M, Miyata K, Nagahori H, Sumida K, Osimitz TG, Cohen SM, Lake BG, Yamada T. 2019. Involvement of peroxisome proliferator-activated receptor-alpha in liver tumor production by permethrin in the female mouse. Toxicol Sci. 168(2):572–696.
   PubMed Web of Science ®Google Scholar
• Kostka G, Kopeć-Szlezak J, Palut D. 1996. Early hepatic changes induced in rats by two hepatocarcinogenic organohalogen pesticides: bromopropylate and DDT. Carcinogenesis. 17(3):407–412.
   PubMed Web of Science ®Google Scholar
• La Vecchia C, Negri E. 2014. A review of epidemiological data on epilepsy, phenobarbital, and risk of liver cancer. Eur J Cancer Prev. 23(1):1–7.
   PubMed Web of Science ®Google Scholar
• Lake BG. 1997. In vitro methods. In: McCuskey RS, Earnest DL, editors. Comprehensive toxicology. Volume 9. Hepatic and gastrointestinal toxicology. Oxford (UK): Elsevier Science Ltd; p. 233–249.
   Google Scholar
• Lake BG. 2009. Species differences in the hepatic effects of inducers of CYP2B and CYP4A subfamily forms: relationship to rodent liver tumour formation. Xenobiotica. 39(8):582–596.
   PubMed Web of Science ®Google Scholar
• Lake BG. 2018. Human relevance of rodent liver tumour formation by constitutive androstane receptor (CAR) activators. Toxicol Res (Camb). 7(4):697–717.
   PubMed Web of Science ®Google Scholar
• Lake BG, Price RJ. 2016. Induction of hepatic cytochrome P450 enzymes: importance in drug development and toxicity. In: Wilson AGE, editor. New horizons in predictive drug metabolism and pharmacokinetics. Cambridge (UK): RSC Publishing; p. 309–332.
   Google Scholar
• Lake BG, Price RJ, Scott MP, Chatham LR, Vardy A, Osimitz TG. 2020. Piperonyl butoxide: mode of action analysis for mouse liver tumour formation and human relevance. Toxicology. 439:152465.
   PubMed Web of Science ®Google Scholar
• Lake BG, Renwick AB, Cunninghame ME, Price RJ, Surry D, Evans DC. 1998. Comparison of the effects of some CYP3A and other enzyme inducers on replicative DNA synthesis and cytochrome P450 isoforms in rat liver. Toxicology. 131(1):9–20.
   PubMed Web of Science ®Google Scholar
• LaRocca JL, Rasoulpour RJ, Gollapudi BB, Eisenbrandt DL, Murphy LA, LeBaron MJ. 2017. Integration of novel approaches demonstrates simultaneous metabolic inactivation and CAR-mediated hepatocarcinogenesis of a nitrification inhibitor. Toxicol Rep. 4:586–597.
   PubMed Web of Science ®Google Scholar
• LeBaron MJ, Gollapudi BB, Terry C, Billington R, Rasoulpour RJ. 2014a. Human relevance framework for rodent liver tumors induced by the insecticide sulfoxaflor. Crit Rev Toxicol. 44(Suppl. 2):15–24.
   PubMedGoogle Scholar
• LeBaron MJ, Rasoulpour RJ, Gollapudi BB, Sura R, Kan HL, Schisler MR, Pottenger LH, Papineni S, Eisenbrandt DL. 2014b. Characterization of nuclear receptor-mediated murine hepatocarcinogenesis of the herbicide pronamide and its human relevance. Toxicol Sci. 142(1):74–92.
   PubMed Web of Science ®Google Scholar
• LeBaron MJ, Geter DR, Rasoulpour RJ, Gollapudi BB, Thomas J, Murray J, Kan HL, Wood AJ, Elcombe C, Vardy A, et al. 2013. An integrated approach for prospectively investigating a mode-of-action for rodent liver effects. Toxicol Appl Pharmacol. 270(2):164–173.
   PubMed Web of Science ®Google Scholar
• Luijten M, Corvi R, Mehta J, Corvaro M, Delrue N, Felter S, Haas B, Hewitt NJ, Hilton G, Holmes T, et al. 2020. A comprehensive view on mechanistic approaches for cancer risk assessment of non-genotoxic agrochemicals. Regul Toxicol Pharmacol. 118:104789.
   PubMed Web of Science ®Google Scholar
• Luisier R, Lempiäinen H, Scherbichler N, Braeuning A, Geissler M, Dubost V, Müller A, Scheer N, Chibout S-D, Hara H, et al. 2014. Phenobarbital induces cell cycle transcriptional responses in mouse liver humanized for constitutive androstane and pregnane x receptors. Toxicol Sci. 139(2):501–511.
   PubMed Web of Science ®Google Scholar
• Lynch C, Mackowiak B, Huang R, Li L, Heyward S, Sakamuru S, Wang H, Xia M. 2019. Identification of modulators that activate the constitutive androstane receptor from the Tox21 10k compound library. Toxicol Sci. 167(1):282–292.
   PubMed Web of Science ®Google Scholar
• Maeda J, Inoue K, Ichimura R, Takahashi M, Kodama Y, Saito N, Yoshida M. 2015. Essential role of constitutive androstane receptor in Ginkgo biloba extract induced liver hypertrophy and hepatocarcinogenesis. Food Chem Toxicol. 83:201–209.
   PubMed Web of Science ®Google Scholar
• Maglich JM, Stoltz CM, Goodwin B, Hawkins-Brown D, Moore JT, Kliewer SA. 2002. Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol. 62(3):638–646.
   PubMed Web of Science ®Google Scholar
• Martignoni M, Groothuis GMM, de Kanter R. 2006. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol. 2(6):875–894.
   PubMed Web of Science ®Google Scholar
• Marx-Stoelting P, Knebel C, Braeuning A. 2020. The connection of azole fungicides with xeno-sensing nuclear receptors, drug metabolism and hepatotoxicity. Cells. 9:1192.
   Web of Science ®Google Scholar
• Masumoto N, Tateno C, Tachibana A, Utoh R, Morikawa Y, Shimada T, Momisako H, Itamoto T, Asahara T, Yoshizato K. 2007. GH enhances proliferation of human hepatocytes grafted into immunodeficient mice with damaged liver. J Endocrinol. 194(3):529–537.
   PubMed Web of Science ®Google Scholar
• Mattu S, Saliba C, Sulas P, Zavattari P, Perra A, Kowalik MA, Monga SP, Columbano A. 2018. High frequency of β-catenin mutations in mouse hepatocellular carcinomas induced by a nongenotoxic constitutive androstane receptor agonist. Am J Pathol. 188(11):2497–2507.
   PubMed Web of Science ®Google Scholar
• Meek ME, Boobis A, Cote I, Dellarco V, Fotakis G, Munn S, Seed J, Vickers C. 2014a. New developments in the evolution and application of the WHO/IPCS framework on mode of action/species concordance analysis. J Appl Toxicol. 34(1):1–18.
   PubMed Web of Science ®Google Scholar
• Meek ME, Bucher JR, Cohen SM, Dellarco V, Hill RN, Lehman-McKeeman LD, Longfellow DG, Pastoor T, Seed J, Patton DE. 2003. A framework for human relevance analysis of information on carcinogenic modes of action. Crit Rev Toxicol. 33(6):591–653.
   PubMed Web of Science ®Google Scholar
• Meek ME, Palermo CM, Bachman AN, North CM, Jeffrey Lewis R. 2014b. Mode of action human relevance (species concordance) framework: evolution of the Bradford Hill considerations and comparative analysis of weight of evidence. J Appl Toxicol. 34(6):595–606.
   PubMed Web of Science ®Google Scholar
• Monro A. 1993. The paradoxical lack of interspecies correlation between plasma concentrations and chemical carcinogenicity. Regul Toxicol Pharmacol. 18(1):115–135.
   PubMed Web of Science ®Google Scholar
• Moolgavkar SH, Knudson AG. 1981. Mutation and cancer: a model for human carcinogenesis. J Natl Cancer Inst. 66(6):1037–1052.
   PubMed Web of Science ®Google Scholar
• Negishi M, Kobayashi K, Sakuma T, Sueyoshi T. 2020. Nuclear receptor phosphorylation in xenobiotic signal transduction. J Biol Chem. 295(45):15210–15225.
   PubMed Web of Science ®Google Scholar
• Nihira K, Nan-Ya KI, Kakuni M, Ono Y, Yoshikawa Y, Ota T, Hiura M, Yoshinari K. 2019. Chimeric mice with humanized livers demonstrate human-specific hepatotoxicity caused by a therapeutic antibody against TRAIL-receptor 2/death receptor 5. Toxicol Sci. 167(1):190–201.
   PubMed Web of Science ®Google Scholar
• Niu B, Coslo DM, Bataille AR, Albert I, Pugh BF, Omiecinski CJ. 2018. In vivo genome-wide binding interactions of mouse and human constitutive androstane receptors reveal novel gene targets. Nucleic Acids Res. 46(16):8385–8403.
   PubMed Web of Science ®Google Scholar
• Ohara A, Takahashi Y, Kondo M, Okuda Y, Takeda S, Kushida M, Kobayashi K, Sumida K, Yamada T. 2017. Candidate genes responsible for early key events of phenobarbital-promoted mouse hepatocellular tumorigenesis based on differentiation of regulating genes between wild type mice and humanized chimeric mice. Toxicol Res (Camb). 6(6):795–813.
   PubMed Web of Science ®Google Scholar
• Okuda Y, Kushida M, Kikumoto H, Nakamura Y, Higuchi H, Kawamura S, Cohen SM, Lake BG, Yamada T. 2017a. Evaluation of the human relevance of the constitutive androstane receptor-mediated mode of action for rat hepatocellular tumor formation by the synthetic pyrethroid momfluorothrin. J Toxicol Sci. 42(6):773–788.
   PubMed Web of Science ®Google Scholar
• Okuda Y, Kushida M, Sumida K, Nagahori H, Nakamura Y, Higuchi H, Kawamura S, Lake BG, Cohen SM, Yamada T. 2017b. Editor's highlight: mode of action analysis for rat hepatocellular tumors produced by the synthetic pyrethroid momfluorothrin: evidence for activation of the constitutive androstane receptor and mitogenicity in rat hepatocytes. Toxicol Sci. 158(2):412–430.
   PubMed Web of Science ®Google Scholar
• Omiecinski CJ, Coslo DM, Chen T, Laurenzana EM, Peffer RC. 2011a. Multi-species analyses of direct activators of the constitutive androstane receptor. Toxicol Sci. 123(2):550–562.
   PubMed Web of Science ®Google Scholar
• Omiecinski CJ, Vanden Heuvel JP, Perdew GH, Peters JM. 2011b. Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities. Toxicol Sci. 120(Suppl. 1):S49–S75.
   PubMedGoogle Scholar
• Oshida K, Vasani N, Jones C, Moore T, Hester S, Nesnow S, Auerbach S, Geter DR, Aleksunes LM, Thomas RS, et al. 2015a. Identification of chemical modulators of the constitutive activated receptor (CAR) in a gene expression compendium. Nucl Recept Signal. 13:e002.
   PubMedGoogle Scholar
• Oshida K, Vasani N, Thomas RS, Applegate D, Gonzalez FJ, Aleksunes LM, Klaassen CD, Corton JC. 2015b. Screening a mouse liver gene expression compendium identifies modulators of the aryl hydrocarbon receptor (AhR). Toxicology. 336:99–112.
   PubMed Web of Science ®Google Scholar
• Oshida K, Vasani N, Thomas RS, Applegate D, Rosen M, Abbott B, Lau C, Guo G, Aleksunes LM, Klaassen C, et al. 2015c. Identification of modulators of the nuclear receptor peroxisome proliferator-activated receptor α (PPARα) in a mouse liver gene expression compendium. PLoS One. 10(2):e0112655.
   PubMed Web of Science ®Google Scholar
• Osimitz TG, Droege W, Boobis AR, Lake BG. 2013. Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humans. Food Chem Toxicol. 60:550–562.
   PubMed Web of Science ®Google Scholar
• Osimitz TG, Lake BG. 2009. Mode-of-action analysis for induction of rat liver tumors by pyrethrins: relevance to human cancer risk. Crit Rev Toxicol. 39(6):501–511.
   PubMed Web of Science ®Google Scholar
• Parkinson A, Leonard N, Draper A, Ogilvie BW. 2006. On the mechanism of hepatocarcinogenesis of benzodiazepines: evidence that diazepam and oxazepam are CYP2B inducers in rats, and both CYP2B and CYP4A inducers in mice. Drug Metab Rev. 38(1–2):235–259.
   PubMed Web of Science ®Google Scholar
• Parkinson A, Mudra DR, Johnson C, Dwyer A, Carroll KM. 2004. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicol Appl Pharmacol. 199(3):193–209.
   PubMed Web of Science ®Google Scholar
• Parzefall W, Erber E, Sedivy R, Schulte-Hermann R. 1991. Testing for induction of DNA synthesis in human hepatocyte primary cultures by rat liver tumor promoters. Cancer Res. 51(4):1143–1147.
   PubMed Web of Science ®Google Scholar
• Peffer RC, Cowie DE, Currie RA, Minnema DJ. 2018a. Sedaxane-use of nuclear receptor transactivation assays, toxicogenomics, and toxicokinetics as part of a mode of action framework for rodent liver tumors. Toxicol Sci. 162(2):582–598.
   PubMed Web of Science ®Google Scholar
• Peffer RC, LeBaron MJ, Battalora M, Bomann WH, Werner C, Aggarwal M, Rowe RR, Tinwell H. 2018b. Minimum datasets to establish a CAR-mediated mode of action for rodent liver tumors. Regul Toxicol Pharmacol. 96:106–120.
   PubMed Web of Science ®Google Scholar
• Peffer RC, Moggs JG, Pastoor T, Currie RA, Wright J, Milburn G, Waechter F, Rusyn I. 2007. Mouse liver effects of cyproconazole, a triazole fungicide: role of the constitutive androstane receptor. Toxicol Sci. 99(1):315–325.
   PubMed Web of Science ®Google Scholar
• Pinne M, Ponce E, Raucy JL. 2016. Transactivation assays to assess canine and rodent pregnane x receptor (PXR) and constitutive androstane receptor (CAR) activation. PLoS One. 11(10):e0164642.
   PubMed Web of Science ®Google Scholar
• Pinne M, Ponce E, Raucy JL. 2017. Transactivation assays that identify indirect and direct activators of human pregnane x receptor (PXR, NR1I2) and constitutive androstane receptor (CAR, NR1I3). Drug Metab Lett. 11(2):128–137.
   PubMedGoogle Scholar
• Plummer S, Beaumont B, Wallace S, Ball G, Wright J, McInnes L, Currie R, Peffer R, Cowie D. 2019. Cross-species comparison of CAR-mediated procarcinogenic key events in a 3D liver microtissue model. Toxicol Rep. 6:998–1005.
   PubMed Web of Science ®Google Scholar
• Price RJ, Giddings AM, Scott MP, Walters DG, Capen CC, Osimitz TG, Lake BG. 2008. Effect of pyrethrins on cytochrome P450 forms in cultured rat and human hepatocytes. Toxicology. 243(1–2):84–95.
   PubMed Web of Science ®Google Scholar
• Price RJ, Walters DG, Finch JM, Gabriel KL, Capen CC, Osimitz TG, Lake BG. 2007. A mode of action for induction of liver tumors by pyrethrins in the rat. Toxicol Appl Pharmacol. 218(2):186–195.
   PubMed Web of Science ®Google Scholar
• Rignall B, Braeuning A, Buchmann A, Schwarz M. 2011. Tumor formation in liver of conditional β-catenin-deficient mice exposed to a diethylnitrosamine/phenobarbital tumor promotion regimen. Carcinogenesis. 32(1):52–57.
   PubMed Web of Science ®Google Scholar
• Riva L, Pandiri AR, Li YR, Droop A, Hewinson J, Quail MA, Iyer V, Shepherd R, Herbert RA, Campbell PJ, et al. 2020. The mutational signature profile of known and suspected human carcinogens in mice. Nat Genet. 52(11):1189–1197.
   PubMed Web of Science ®Google Scholar
• Rooney J, Hill T 3rd, Qin C, Sistare FD, Christopher Corton J. 2018. Adverse outcome pathway-driven identification of rat liver tumorigens in short-term assays. Toxicol Appl Pharmacol. 356:99–113.
   PubMed Web of Science ®Google Scholar
• Rooney JP, Oshida K, Kumar R, Baldwin WS, Corton JC. 2019. Chemical activation of the constitutive androstane receptor leads to activation of oxidant-induced Nrf2. Toxicol Sci. 167(1):172–189.
   PubMed Web of Science ®Google Scholar
• Ross J, Plummer SM, Rode A, Scheer N, Bower CC, Vogel O, Henderson CJ, Wolf CR, Elcombe CR. 2010. Human constitutive androstane receptor (CAR) and pregnane X receptor (PXR) support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogens phenobarbital and chlordane in vivo. Toxicol Sci. 116(2):452–466.
   PubMed Web of Science ®Google Scholar
• Rossi L, Barbieri O, Sanguineti M, Cabral JR, Bruzzi P, Santi L. 1983. Carcinogenicity study with technical-grade dichlorodiphenyltrichloroethane and 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene in hamsters. Cancer Res. 43(2):776–781.
   PubMed Web of Science ®Google Scholar
• Sakamoto Y, Inoue K, Takahashi M, Taketa Y, Kodama Y, Nemoto K, Degawa M, Gamou T, Ozawa S, Nishikawa A, et al. 2013. Different pathways of constitutive androstane receptor-mediated liver hypertrophy and hepatocarcinogenesis in mice treated with piperonyl butoxide or decabromodiphenyl ether. Toxicol Pathol. 41(8):1078–1092.
   PubMed Web of Science ®Google Scholar
• Sakamoto Y, Yoshida M, Tamura K, Takahashi M, Kodama Y, Inoue K. 2015. Dose-dependent difference of nuclear receptors involved in murine liver hypertrophy by piperonyl butoxide. J Toxicol Sci. 40(6):787–796.
   PubMed Web of Science ®Google Scholar
• Scheer N, Ross J, Rode A, Zevnik B, Niehaves S, Faust N, Wolf CR. 2008. A novel panel of mouse models to evaluate the role of human pregnane X receptor and constitutive androstane receptor in drug response. J Clin Invest. 118(9):3228–3239.
   PubMed Web of Science ®Google Scholar
• Seed J, Carney EW, Corley RA, Crofton KM, DeSesso JM, Foster PM, Kavlock R, Kimmel G, Klaunig J, Meek ME, et al. 2005. Overview: using mode of action and life stage information to evaluate the human relevance of animal toxicity data. Crit Rev Toxicol. 35(8–9):664–672.
   PubMed Web of Science ®Google Scholar
• Seglen PO. 1976. Preparation of isolated rat liver cells. Methods Cell Biol. 13:29–83.
   PubMedGoogle Scholar
• Shizu R, Benoki S, Numakura Y, Kodama S, Miyata M, Yamazoe Y, Yoshinari K. 2013. Xenobiotic-induced hepatocyte proliferation associated with constitutive active/androstane receptor (CAR) or peroxisome proliferator-activated receptor α (PPARα) is enhanced by pregnane X receptor (PXR) activation in mice. PLoS One. 8(4):e61802.
   PubMed Web of Science ®Google Scholar
• Shizu R, Ishimura M, Nobusawa S, Hosaka T, Sasaki T, Kakizaki S, Yoshinari K. 2021. The influence of the long-term chemical activation of the nuclear receptor pregnane X receptor (PXR) on liver carcinogenesis in mice. Arch Toxicol. 95(3):1089–1102.
   PubMed Web of Science ®Google Scholar
• Shizu R, Yoshinari K. 2020. Nuclear receptor CAR-mediated liver cancer and its species differences. Expert Opin Drug Metab Toxicol. 16(4):343–351.
   PubMed Web of Science ®Google Scholar
• Sidaway JE, Orton TC, Kalaitzi K, Jones HB, Foster A, Lake BG. 2020. Analysis of β-catenin gene mutations and gene expression in liver tumours of C57BL/10J mice produced by chronic administration of sodium phenobarbital. Toxicology. 430:152343.
   PubMed Web of Science ®Google Scholar
• Sistare FD, Morton D, Alden C, Christensen J, Keller D, Jonghe SD, Storer RD, Reddy MV, Kraynak A, Trela B, et al. 2011. An analysis of pharmaceutical experience with decades of rat carcinogenicity testing: support for a proposal to modify current regulatory guidelines. Toxicol Pathol. 39(4):716–744.
   PubMed Web of Science ®Google Scholar
• Skoda J, Dusek J, Drastik M, Stefela A, Dohnalova K, Chalupsky K, Smutny T, Micuda S, Gerbal-Chaloin S, Pavek P. 2020. Diazepam promotes translocation of human constitutive androstane receptor (CAR) via direct interaction with the ligand-binding domain. Cells. 9(12):2532.
   Web of Science ®Google Scholar
• Soldatow VY, LeCluyse EL, Griffith LG, Rusyn I. 2013. In vitro models for liver toxicity testing. Toxicol Res (Camb). 2(1):23–39.
   PubMed Web of Science ®Google Scholar
• Soldatow V, Peffer RC, Trask OJ, Cowie DE, Andersen ME, LeCluyse E, Deisenroth C. 2016. Development of an in vitro high content imaging assay for quantitative assessment of CAR-dependent mouse, rat, and human primary hepatocyte proliferation. Toxicol In Vitro. 36:224–237.
   PubMed Web of Science ®Google Scholar
• Sonich-Mullin C, Fielder R, Wiltse J, Baetcke K, Dempsey J, Fenner-Crisp P, Grant D, Hartley M, Knaap A, Kroese D, et al. 2001. IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul Toxicol Pharmacol. 34(2):146–152.
   PubMed Web of Science ®Google Scholar
• Stanley LA, Horsburgh BC, Ross J, Scheer N, Wolf CR. 2006. PXR and CAR: nuclear receptors which play a pivotal role in drug disposition and chemical toxicity. Drug Metab Rev. 38(3):515–597.
   PubMed Web of Science ®Google Scholar
• Staudinger J, Liu Y, Madan A, Habeebu S, Klaassen CD. 2001. Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. Drug Metab Dispos. 29(11):1467–1472.
   PubMed Web of Science ®Google Scholar
• Stenbäck F, Mori H, Furuya K, Williams GM. 1986. Pathogenesis of dimethylnitrosamine-induced hepatocellular cancer in hamster liver and lack of enhancement by phenobarbital. J Natl Cancer Inst. 76(2):327–333.
   PubMedGoogle Scholar
• Stevenson DE, Walborg EF, North DW, Sielken RL, Ross CE, Wright AS, Xu Y, Kamendulis LM, Klaunig JE. 1999. Monograph: reassessment of human cancer risk of aldrin/dieldrin. Toxicol Lett. 109(3):123–186.
   PubMed Web of Science ®Google Scholar
• Strathmann J, Schwarz M, Tharappel JC, Glauert HP, Spear BT, Robertson LW, Appel KE, Buchmann A. 2006. PCB 153, a non-dioxin-like tumor promoter, selects for beta-catenin (Catnb)-mutated mouse liver tumors. Toxicol Sci. 93(1):34–40.
   PubMed Web of Science ®Google Scholar
• Stritzelberger J, Lang JD, Mueller TM, Reindl C, Westermayer V, Kostev K, Hamer HM. 2021. Anti-seizure medication is not associated with an increased risk to develop cancer in epilepsy patients. J Neurol. 268(6):2185–2191.
   PubMed Web of Science ®Google Scholar
• Strupp C, Quesnot N, Richert L, Moore J, Bomann WH, Singh P. 2020. Weight of evidence and human relevance evaluation of the benfluralin mode of action in rodents (Part I): liver carcinogenesis. Regul Toxicol Pharmacol. 117:104758.
   PubMed Web of Science ®Google Scholar
• Sugahara G, Ishida Y, Sun J, Tateno C, Saito T. 2020. Art of making artificial liver: depicting human liver biology and diseases in mice. Semin Liver Dis. 40(2):189–212.
   PubMed Web of Science ®Google Scholar
• Takayama S, Sieber SM, Dalgard DW, Thorgeirsson UP, Adamson RH. 1999. Effects of long-term oral administration of DDT on nonhuman primates. J Cancer Res Clin Oncol. 125(3–4):219–225.
   PubMed Web of Science ®Google Scholar
• Tamura K, Inoue K, Takahashi M, Matsuo S, Irie K, Kodama Y, Gamo T, Ozawa S, Yoshida M. 2015. Involvement of constitutive androstane receptor in liver hypertrophy and liver tumor development induced by triazole fungicides. Food Chem Toxicol. 78:86–95.
   PubMed Web of Science ®Google Scholar
• Tamura K, Inoue K, Takahashi M, Matsuo S, Irie K, Kodama Y, Ozawa S, Nishikawa A, Yoshida M. 2013. Dose–response involvement of constitutive androstane receptor in mouse liver hypertrophy induced by triazole fungicides. Toxicol Lett. 221(1):47–56.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Mori H, Williams GM. 1987. Enhancement of dimethylnitrosamine-initiated hepatocarcinogenesis in hamsters by subsequent administration of carbon tetrachloride but not phenobarbital or p,p′-dichlorodiphenyltrichloroethane. Carcinogenesis. 8(9):1171–1178.
   PubMed Web of Science ®Google Scholar
• Tateishi T, Asoh M, Nakura H, Watanabe M, Tanaka M, Kumai T, Kobayashi S. 1999. Carbamazepine induces multiple cytochrome P450 subfamilies in rats. Chem Biol Interact. 117(3):257–268.
   PubMed Web of Science ®Google Scholar
• Tateno C, Kojima Y. 2020. Characterization and applications of chimeric mice with humanized livers for preclinical drug development. Lab Anim Res. 36:2.
   PubMed Web of Science ®Google Scholar
• Tateno C, Yamamoto T, Utoh R, Yamasaki C, Ishida Y, Myoken Y, Oofusa K, Okada M, Tsutsui N, Yoshizato K. 2015. Chimeric mice with hepatocyte-humanized liver as an appropriate model to study human peroxisome proliferator-activated receptor-α. Toxicol Pathol. 43(2):233–248.
   PubMed Web of Science ®Google Scholar
• Thatcher NJ, Caldwell J. 1994. Origins of hepatomegaly produced by dexamethasone (DEX), pregnenolone 16 alpha-carbonitrile (PCN) and phenobarbitone (PB) in female Sprague-Dawley rats. Biochem Soc Trans. 22(2):132S.
   PubMed Web of Science ®Google Scholar
• Thompson MD, Monga SP. 2007. WNT/beta-catenin signaling in liver health and disease. Hepatology. 45(5):1298–1305.
   PubMed Web of Science ®Google Scholar
• Thoolen B, Ten Kate FJ, van Diest PJ, Malarkey DE, Elmore SA, Maronpot RR. 2012. Comparative histomorphological review of rat and human hepatocellular proliferative lesions. J Toxicol Pathol. 25(3):189–199.
   PubMed Web of Science ®Google Scholar
• Thoolen B, Maronpot RR, Harada T, Nyska A, Rousseaux C, Nolte T, Malarkey DE, Kaufmann W, Küttler K, Deschl U, et al. 2010. Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system. Toxicol Pathol. 38(7 Suppl.):5S–81S.
   PubMed Web of Science ®Google Scholar
• Tinwell H, Rouquie D, Schorsch F, Geter D, Wason S, Bars R. 2014. Liver tumor formation in female rat induced by fluopyram is mediated by CAR/PXR nuclear receptor activation. Regul Toxicol Pharmacol. 70(3):648–658.
   PubMed Web of Science ®Google Scholar
• Tucker MJ, Orton TC. 1995. Comparative toxicology of hypolipidaemic fibrates. London: Taylor & Francis.
   Google Scholar
• Wang Z, Neal BH, Lamb JC, Klaunig JE. 2015. Mechanistic investigation of toxaphene induced mouse liver tumors. Toxicol Sci. 147(2):549–561.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wu Q, Li X, Klaunig JE. 2020. Constitutive androstane receptor (CAR) mediates dieldrin-induced liver tumorigenesis in mouse. Arch Toxicol. 94(8):2873–2884.
   PubMed Web of Science ®Google Scholar
• Wang Z, Li X, Wu Q, Lamb JC, Klaunig JE. 2017. Toxaphene-induced mouse liver tumorigenesis is mediated by the constitutive androstane receptor. J Appl Toxicol. 37(8):967–975.
   PubMed Web of Science ®Google Scholar
• Ward WO, Delker DA, Hester SD, Thai SF, Wolf DC, Allen JW, Nesnow S. 2006. Transcriptional profiles in liver from mice treated with hepatotumorigenic and nonhepatotumorigenic triazole conazole fungicides: propiconazole, triadimefon, and myclobutanil. Toxicol Pathol. 34(7):863–878.
   PubMed Web of Science ®Google Scholar
• Wei P, Zhang J, Egan-Hafley M, Liang S, Moore DD. 2000. The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature. 407(6806):920–923.
   PubMed Web of Science ®Google Scholar
• Whysner J, Ross PM, Williams GM. 1996. Phenobarbital mechanistic data and risk assessment: enzyme induction, enhanced cell proliferation, and tumor promotion. Pharmacol Ther. 71(1–2):153–191.
   PubMed Web of Science ®Google Scholar
• Wiemann C, Goettel M, Vardy A, Elcombe BM, Elcombe CR, Chatham LR, Wang H, Li L, Buesen R, Honarvar N, et al. 2019. Metazachlor: mode of action analysis for rat liver tumour formation and human relevance. Toxicology. 426:152282.
   PubMed Web of Science ®Google Scholar
• Wolf DC, Cohen SM, Boobis AR, Dellarco VL, Fenner-Crisp PA, Moretto A, Pastoor TP, Schoeny RS, Seed JG, Doe JE. 2019. Chemical carcinogenicity revisited 1: a unified theory of carcinogenicity based on contemporary knowledge. Regul Toxicol Pharmacol. 103(10386):86–92.
   PubMedGoogle Scholar
• Wood CE, Hukkanen RR, Sura R, Jacobson-Kram D, Nolte T, Odin M, Cohen SM. 2015. Scientific and regulatory policy committee (SRPC) review: interpretation and use of cell proliferation data in cancer risk assessment. Toxicol Pathol. 43(6):760–775.
   PubMed Web of Science ®Google Scholar
• Yamada T. 2018. Case examples of an evaluation of the human relevance of the pyrethroids/pyrethrins-induced liver tumours in rodents based on the mode of action. Toxicol Res (Camb). 7(4):681–696.
   PubMed Web of Science ®Google Scholar
• Yamada T, Kikumoto H, Lake BG, Kawamura S. 2015. Lack of effect of metofluthrin and sodium phenobarbital on replicative DNA synthesis and Ki-67 mRNA expression in cultured human hepatocytes. Toxicol Res. 4(4):901–913.
   Web of Science ®Google Scholar
• Yamada T, Ohara A, Ozawa N, Maeda K, Kondo M, Okuda Y, Abe J, Cohen SM, Lake BG. 2020. Comparison of the hepatic effects of phenobarbital in chimeric mice containing either rat or human hepatocytes with humanized constitutive androstane receptor and pregnane X receptor mice. Toxicol Sci. 177(2):362–376.
   PubMed Web of Science ®Google Scholar
• Yamada T, Okuda Y, Kushida M, Sumida K, Takeuchi H, Nagahori H, Fukuda T, Lake BG, Cohen SM, Kawamura S. 2014. Human hepatocytes support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogen sodium phenobarbital in an in vivo study using a chimeric mouse with humanized liver. Toxicol Sci. 142(1):137–157.
   PubMed Web of Science ®Google Scholar
• Yamada T, Uwagawa S, Okuno Y, Cohen SM, Kaneko H. 2009. Case study: an evaluation of the human relevance of the synthetic pyrethroid metofluthrin-induced liver tumors in rats based on mode of action. Toxicol Sci. 108(1):59–68.
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Moore R, Goldsworthy TL, Negishi M, Maronpot RR. 2004. The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res. 64(20):7197–7200.
   PubMed Web of Science ®Google Scholar
• Yang H, Wang H. 2014. Signaling control of the constitutive androstane receptor (CAR). Protein Cell. 5(2):113–123.
   PubMed Web of Science ®Google Scholar
• Yano BL, Hardisty JF, Seely JC, Butterworth BE, McConnell EE, Swenberg JA, Williams GM, Stebbins KE, Golllapudi BB, Eisenbrandt DL. 2008. Nitrapyrin: a scientific advisory group review of the mode of action and carcinogenicity in B6C3F1 mice. Regul Toxicol Pharmacol. 51(1):53–65.
   PubMed Web of Science ®Google Scholar
• Yoshinari K. 2019. Role of nuclear receptors PXR and CAR in xenobiotic-induced hepatocyte proliferation and chemical carcinogenesis. Biol Pharm Bull. 42(8):1243–1252.
   PubMed Web of Science ®Google Scholar
• Yoshinari K, Ueda R, Kusano K, Yoshimura T, Nagata K, Yamazoe Y. 2008. Omeprazole transactivates human CYP1A1 and CYP1A2 expression through the common regulatory region containing multiple xenobiotic-responsive elements. Biochem Pharmacol. 76(1):139–145.
   PubMed Web of Science ®Google Scholar